147 related articles for article (PubMed ID: 34736487)
21. Ovarian Sertoli Leydig cell tumours in children and adolescents: an analysis of the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT).
Schneider DT; Orbach D; Cecchetto G; Stachowicz-Stencel T; Brummel B; Brecht IB; Bisogno G; Ferrari A; Reguerre Y; Godzinski J; Bien E; Calaminus G; Göbel U; Patte C
Eur J Cancer; 2015 Mar; 51(4):543-550. PubMed ID: 25514863
[TBL] [Abstract][Full Text] [Related]
22. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
[TBL] [Abstract][Full Text] [Related]
23. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
[TBL] [Abstract][Full Text] [Related]
24. Sertoli-Leydig cell tumor: a clinicopathological analysis in a comprehensive, national cohort.
Bekker P; Miland-Samuelsen AR; Smerdel MP; Schnack TH; Lauszus FF; Karstensen SH
Int J Gynecol Cancer; 2023 Dec; 33(12):1921-1927. PubMed ID: 37907261
[TBL] [Abstract][Full Text] [Related]
25. Sertoli-Leydig cell tumors: current status of surgical management: literature review and proposal of treatment.
Litta P; Saccardi C; Conte L; Codroma A; Angioni S; Mioni R
Gynecol Endocrinol; 2013 May; 29(5):412-7. PubMed ID: 23379421
[TBL] [Abstract][Full Text] [Related]
26. DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors.
de Kock L; Terzic T; McCluggage WG; Stewart CJR; Shaw P; Foulkes WD; Clarke BA
Am J Surg Pathol; 2017 Sep; 41(9):1178-1187. PubMed ID: 28654427
[TBL] [Abstract][Full Text] [Related]
27. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.
Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD
Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392
[TBL] [Abstract][Full Text] [Related]
28. Sertoli-Leydig cell tumor of the ovary.
Chen FY; Sheu BC; Lin MC; Chow SN; Lin HH
J Formos Med Assoc; 2004 May; 103(5):388-91. PubMed ID: 15216408
[TBL] [Abstract][Full Text] [Related]
29. Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution.
Yang B; Chour W; Salazar CG; Zamiara P; Schmidt RJ; Raca G; Shillingford N; Zhou S; Warren M; Parham DM; Pawel B; Wang LL
Am J Surg Pathol; 2024 Feb; 48(2):194-203. PubMed ID: 37946548
[TBL] [Abstract][Full Text] [Related]
30. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors.
Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y
Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933
[TBL] [Abstract][Full Text] [Related]
31. Retiform pattern of Sertoli-Leydig cell tumor of the ovary in a 4-year-old girl.
Kawatra V; Mandal S; Khurana N; Aggarwal SK
J Obstet Gynaecol Res; 2009 Feb; 35(1):176-9. PubMed ID: 19215568
[TBL] [Abstract][Full Text] [Related]
32. What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome.
Candotti G; Peiretti M; Mangili G; Bergamini A; Candiani M; Cioffi R; Mais V; Rabaiotti E; Bocciolone L
Eur J Surg Oncol; 2020 May; 46(5):888-892. PubMed ID: 31722834
[TBL] [Abstract][Full Text] [Related]
33. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
Chen RF; Li J; Zhu TT; Yu HL; Lu X
J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
[TBL] [Abstract][Full Text] [Related]
34. Sertoli-Leydig cell tumor of the ovary: a clinicopathologic study of 10 cases.
Ayhan A; Tuncer ZS; Hakverdi AU; Yüce K; Ayhan A
Eur J Gynaecol Oncol; 1996; 17(1):75-8. PubMed ID: 8750520
[TBL] [Abstract][Full Text] [Related]
35. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
[TBL] [Abstract][Full Text] [Related]
36. Sertoli-Leydig cell tumour of the ovary--a rare cause of virilization after menopause.
Hansen TP; Sørensen B
APMIS; 1993 Sep; 101(9):663-6. PubMed ID: 8240784
[TBL] [Abstract][Full Text] [Related]
37. Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian Cancers.
Gouy S; Saidani M; Maulard A; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
Oncologist; 2018 Mar; 23(3):324-327. PubMed ID: 29242280
[TBL] [Abstract][Full Text] [Related]
38. Metastatic Sertoli-Leydig cell ovarian cancer manifested as a frontal sinus mass.
Campisi P; Cheski P
J Otolaryngol; 1998 Dec; 27(6):361-2. PubMed ID: 9857323
[No Abstract] [Full Text] [Related]
39. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
40. A retrospective study of 27 ovarian tumors of low malignant potential.
Demeter A; Csapó Z; Szánthó A; Bálega J; Sipos N; Papp Z
Eur J Gynaecol Oncol; 2002; 23(5):415-8. PubMed ID: 12440814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
